AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Efoglim M 3mg/1000mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Oldmed Healthcare Pvt Ltd

Salt Composition

Glimepiride (3mg) + Metformin (1000mg)

Overview Efoglim M 3mg/1000mg Tablet SR

Diabetics utilizing the sustained-release formulation, Efoglim M (3mg/1000mg), benefit from its anti-diabetic properties. This dual-action medication manages blood glucose in adult type 2 diabetes patients. Administer this tablet with food, consistently at the same time daily, for optimal efficacy. Dosage, determined by your physician, may be adjusted based on blood sugar monitoring. Continuous use is crucial; abrupt cessation, without medical consultation, risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight control as prescribed by your doctor. Commonly, Efoglim M can cause hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, dizziness, headache, and tremors; always carry a fast-acting sugar source. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is also possible. Contraindicated in type 1 diabetes, diabetic ketoacidosis, or severe hepatic/renal impairment. Prior heart disease necessitates discussion with your physician before commencing treatment. Pregnant or lactating individuals require medical consultation. Regular blood sugar checks, along with potential blood tests for blood cell counts and liver function, are recommended under your doctor's supervision.

Primary Ingredients of Efoglim M 3mg/1000mg Tablet SR

No information provided. Please provide the text you wish me to rephrase.

Uses of Efoglim M 3mg/1000mg Tablet SR

Managing type 2 diabetes

Major Benefits of Efoglim M 3mg/1000mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. The Efoglim M 3mg/1000mg sustained-release tablet should be taken with a meal.

Common Side effects of Efoglim M 3mg/1000mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Efoglim M 3mg/1000mg Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Efoglim M 3mg/1000mg SR tablet whole; do not crush, chew, or divide it. Administer this medication with a meal.

How Efoglim M 3mg/1000mg Tablet SR works:

Efoglim M SR tablets (3mg/1000mg) combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose output, slowing intestinal glucose uptake, and improving insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Efoglim M 3mg/1000mg SR tablets with alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Efoglim M 3mg/1000mg tablet might pose risks during pregnancy. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Efoglim M 3mg/1000mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from the medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Efoglim M 3mg/1000mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Efoglim M 3mg/1000mg SR tablets. Physician consultation is recommended. Kidney function should be regularly monitored during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Efoglim M 3mg/1000mg SR tablets cautiously, potentially requiring dosage modification. Individuals with mild to moderate liver disease should begin treatment with a reduced dose; the medication is contraindicated in those with severe liver disease. Physician consultation is advised.

What if you forget to take Efoglim M 3mg/1000mg Tablet SR :

Should you forget to take your Efoglim M 3mg/1000mg SR Tablet, administer it immediately upon remembering. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed amount.

Facts to Know About Efoglim M 3mg/1000mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Efoglim M 3mg/1000mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication; keep it out of reach of children, pets, and others.
Efoglim M 3mg/1000mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Efoglim M 3mg/1000mg Tablet SR and seek immediate medical attention.
Efoglim M 3mg/1000mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Efoglim M 3mg/1000mg SR tablets may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Prolonged use of Efoglim M 3mg/1000mg SR tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake is recommended annually by some researchers.
Efoglim M 3mg/1000mg SR tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Efoglim M 3mg/1000mg SR tablets with alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Efoglim M 3mg/1000mg Tabl...
68
MRP 79
13% off